- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.6: 3 residues within 4Å:- Chain A: A.703, E.1069, N.1071
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.16: 3 residues within 4Å:- Chain B: E.1069, K.1070, N.1071
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.27: 4 residues within 4Å:- Chain C: A.703, E.1069, K.1070, N.1071
No protein-ligand interaction detected (PLIP)- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-MAN.7: 4 residues within 4Å:- Chain A: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.8: 1 residues within 4Å:- Chain A: N.1131
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.17: 4 residues within 4Å:- Chain B: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.18: 1 residues within 4Å:- Chain B: N.1131
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.28: 4 residues within 4Å:- Chain C: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.29: 1 residues within 4Å:- Chain C: N.1131
No protein-ligand interaction detected (PLIP)- 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.30: 2 residues within 4Å:- Chain A: F.59, N.61
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain A: N.120, T.122, V.125, E.151
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: K.144, N.146
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain A: N.162
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain A: T.106, N.231
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain A: N.277, N.279
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain A: G.336, N.340
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain A: N.600
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain A: N.654
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain A: N.706, G.1128
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain A: N.1155
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: K.144, N.146
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.231
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain B: N.328
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain B: N.340, V.364, S.368
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain B: N.600
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain B: N.654
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain B: N.706, G.1128
- Chain C: D.793
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain B: N.1155
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain C: Y.142, K.144, N.146
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain C: N.328, Q.577
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain C: N.340
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.600
Ligand excluded by PLIPNAG.55: 1 residues within 4Å:- Chain C: N.654
Ligand excluded by PLIPNAG.56: 3 residues within 4Å:- Chain A: D.793
- Chain C: N.706, G.1128
Ligand excluded by PLIPNAG.57: 1 residues within 4Å:- Chain C: N.1155
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cai, Y. et al., Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science (2021)
- Release Date
- 2021-07-07
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cai, Y. et al., Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science (2021)
- Release Date
- 2021-07-07
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C